Welcome to our dedicated page for Zapata Quantum SEC filings (Ticker: ZPTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to the SEC filings of Zapata Quantum, Inc. (ZPTA), offering detailed insight into the company’s capital structure, governance, and strategic restructuring. As a publicly traded, hardware‑agnostic quantum software and enterprise AI company, Zapata uses filings such as Forms 10‑K, 10‑Q, and 8‑K to disclose information about its operations, financings, and material events.
For Zapata, current and historical 10‑K and 10‑Q reports are central resources for understanding its business description, risk factors, quantum and AI software focus, and the role of its patent portfolio. These periodic reports also summarize participation in programs like DARPA’s Quantum Benchmarking initiative and describe how the company positions its Orquestra platform and quantum‑inspired models for enterprise and government customers.
The company’s 8‑K filings are especially important given its recent restructuring. They document secured convertible promissory notes, warrants, conversion agreements that exchange liabilities for equity, security and intercreditor agreements, and other transactions that affect shareholders and creditors. Items in these filings explain how Zapata has raised capital, restructured debt, and preserved its intellectual property and strategic assets.
Investors tracking ownership and insider activity can use this page to locate filings that disclose equity awards and grants to key individuals, as reflected in specific 8‑K items. Over time, related forms such as Form 4, when available, can provide additional detail on insider transactions.
Stock Titan enhances these documents with AI-powered summaries that highlight key terms, structural changes, and notable disclosures, helping readers quickly interpret complex agreements and capital arrangements. Real‑time updates from EDGAR ensure that new Zapata Quantum filings appear promptly, while AI analysis helps users identify how each filing relates to the company’s quantum software strategy, IP portfolio, and ongoing efforts to maintain SEC compliance and pursue a return to a national securities exchange.
Zapata Quantum, Inc. (ZPTA) is asking stockholders at the October 9, 2026 virtual annual meeting to elect three directors to staggered one‑, two‑ and three‑year terms, approve a series of potential reverse stock splits, ratify its auditor, and approve advisory votes on executive pay and pay frequency.
The Board seeks authority to implement, at its discretion, a reverse split of common stock between 1‑for‑2 and 1‑for‑50 primarily to help meet initial and continued listing requirements for a Nasdaq or NYSE uplisting, while cautioning there is no assurance a split will achieve or sustain a qualifying share price or listing. As of the September 9, 2026 record date, total voting power was 233,954,484 shares, with CEO/CFO Sumit Kapur and Chairman Clark Golestani each beneficially owning just under 20% of common stock on a diluted basis. The proxy also details related‑party financings, including 2025 insider convertible notes and warrants at $0.04 per share, substantial equity awards to executives and directors, and shows a swing from a $38.1 million net loss in 2024 to $9.3 million net income in 2025.
Zapata Quantum, Inc. is updating its resale registration statement to incorporate its Quarterly Report for the period ended June 30, 2026, covering the resale by selling stockholders of up to 56,816,391 shares of common stock. As of August 3, 2026, common shares outstanding were 187,328,921.
The company reported no revenue and a net loss of $3.1 million for the first half of 2026, with operating expenses of $2.8 million. Liquidity improved after an April 2026 financing that raised $15.0 million gross (net $13.8 million) via Series D preferred stock and warrants, resulting in cash of $12.8 million and stockholders’ equity of $3.1 million at June 30, 2026. Management states existing cash is expected to fund the current operating plan for at least twelve months, though the company continues to incur losses and has material weaknesses in internal controls.
Zapata Quantum, Inc. reported no revenue for the three and six months ended June 30, 2026, reflecting its early-stage, quantum software-focused business model. Operating expenses rose to $1.6 million in the quarter and $2.8 million year-to-date, driven by higher headcount, stock-based compensation and legal/IP costs, resulting in a quarterly net loss of $1.8 million and a six‑month net loss of $3.1 million, versus prior-year profits largely driven by one-time debt extinguishment gains.
Cash improved sharply after an April 2026 financing in which the company issued 15,000 Series D preferred shares (convertible into 34.2 million common shares) plus warrants for gross proceeds of $15.0 million and net proceeds of $13.8 million. Cash rose to $12.8 million and stockholders’ equity turned positive at $3.1 million, and management now expects existing cash to fund its operating plan for at least 12 months, while still anticipating continued losses. The company also reports multiple material weaknesses in internal controls and a large overhang of potentially dilutive securities.
Zapata Quantum, Inc. announced a new partnership with QuEra, a neutral-atom quantum computing company, to advance the commercial viability of quantum applications. The collaboration combines QuEra’s roadmap toward fault-tolerant hardware with Zapata’s hardware-agnostic quantum application and algorithm development capabilities.
The partnership is part of the QuEra Quantum Alliance Program and focuses on helping enterprises, government programs, and HPC centers co-design and validate applications before hardware reaches full fault tolerance. Zapata highlights this as aligned with its broader strategy of working with technology leaders across the quantum and AI ecosystems, alongside an ongoing partnership with NVIDIA to apply agentic AI to quantum algorithm development.
Zapata Quantum, Inc. has filed a resale prospectus covering up to 56,816,391 shares of Common Stock, all to be sold from time to time by existing selling stockholders. These shares are issuable upon conversion or exercise of Series C and Series D preferred stock and related warrants issued in 2025–2026 private placements. The company is not selling shares in this offering and will only receive cash if warrants are exercised.
The company had 187,303,921 shares of Common Stock outstanding before and after the offering, with additional substantial overhang from options, warrants, notes and preferred stock. Zapata describes itself as a hardware-agnostic quantum software company that suspended operations in October 2024 due to liquidity constraints, then restructured debt and raised capital to resume operations in 2025–2026. It reported a $1.3 million net loss and $642 thousand in cash for the quarter ended March 31, 2026, has outstanding $4.0 million in secured notes, and discloses substantial doubt about its ability to continue as a going concern despite management’s expectation that current cash will fund at least twelve months of operations.
Zapata Quantum, Inc. entered into an Exclusive Broker-Dealer and Leak-Out Management Agreement with Chardan Capital Markets LLC to manage potential sales of certain restricted common shares held by stockholders subject to prior Universal Resale and Registration provisions.
Chardan will act as exclusive broker for these sales, earning a 4% commission on gross proceeds until its aggregate commissions reach $200,000, after which the rate drops to 3%. Upon expiration or termination other than for Chardan’s uncured material breach, Zapata must pay an amount so that Chardan receives at least $400,000 in total compensation under the agreement.
Zapata, Inc. furnished an investor presentation outlining its strategy as a quantum software company. The presentation highlights Zapata Quantum as a US‑based publicly traded quantum software leader with over 60 foundational patents, 40+ peer‑reviewed papers, and roots in Harvard’s quantum computing lab.
Management describes a large potential opportunity, citing estimates for a $2TN quantum economic value in 2035 and a $100BN+ platform total addressable market, alongside a current $2BN quantum computing market growing at 35% annually. The deck emphasizes DARPA Quantum Benchmarking program experience, a unified software platform spanning discovery to deployment, and an Intermediate Representation patent viewed as foundational for quantum and hybrid compilation.
Zapata also notes a completed restructuring, including a clean balance sheet with over $20M of debt restructured, new capital from venture investors and quantum specialists, and restored operations with key technical leadership. Potential future catalysts discussed include equity research coverage, uplisting to a national exchange, commercial conversions, partnerships, government programs, and continued scientific and intellectual property progress.
Zapata Quantum, Inc. has filed an amended registration statement covering up to 56,816,391 shares of common stock for resale by existing investors. The company is not selling shares itself and will only receive cash if outstanding warrants are exercised.
There are 187,303,921 shares of common stock currently outstanding, with substantial additional overhang from options, warrants, convertible notes and preferred stock. The filing details a history of operating losses, a prior suspension of operations in 2024, and significant liquidity pressures, including Secured Notes over the company’s assets and substantial doubt about its ability to continue as a going concern.
Zapata Quantum, Inc. announced that CEO Sumit Kapur will present at the Global Technology Virtual Investor Conference on July 9, 2026 at 10:30 a.m. Eastern Time. The event is live and interactive, with an archived webcast available afterward.
The company highlighted a collaboration with NVIDIA to apply agentic AI to accelerate quantum algorithm development through scalable quantum resource estimation. It also cited quantum-enabled drug discovery research, co-authored with leading institutions, that was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025.
Zapata noted a successful restructuring capped by a $15 million fundraise led by Triatomic Capital and expansion of its leadership team, including appointing quantum software pioneer Yudong Cao as CTO. The conference will also offer scheduled one-on-one investor meetings on July 10 and July 14.